歯科用麻酔薬の世界市場2022~2031:麻酔種類別

◆英語タイトル:Dental Anesthetics Market (Type of Anesthesia: Local Anesthesia, General Anesthesia, and Sedation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書(TMR23FB045)◆商品コード:TMR23FB045
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2022年12月26日
◆ページ数:208
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥880,840見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD8,795 ⇒換算¥1,336,840見積依頼/購入/質問フォーム
Corporate License(法人閲覧)USD11,795 ⇒換算¥1,792,840見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社は、2022年に705.5百万ドルであった世界の歯科用麻酔薬市場規模が2031年には904.1百万ドルまで拡大し、予測期間中にCAGR 2.6%増加すると見込んでいます。本資料では、歯科用麻酔薬の世界市場を総合的に調査・分析を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、麻酔種類別(局所麻酔、全身麻酔、鎮静剤)分析、投与経路別(経口、静脈内、その他)分析、エンドユーザー別(病院、歯科医院、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競合状況などの内容を調査資料にまとめました。なお、本資料では、3M、Aspen Group、Centrix, Inc.、Crosstex International, Inc. 、Dentalhitec、Dentsply Sirona、Laboratorios Inibsa、Laboratorios Normon、Pierrel SPA、Primex Pharmaceuticals、Septodont、Zeyco、Southern Anesthesia & Surgical, Inc.、Milestone Scientificなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要洞察
・世界の歯科用麻酔薬市場規模:麻酔種類別
- 局所麻酔の市場規模
- 全身麻酔の市場規模
- 鎮静剤の市場規模
・世界の歯科用麻酔薬市場規模:投与経路別
- 経口投与における市場規模
- 静脈内投与における市場規模
- その他投与における市場規模
・世界の歯科用麻酔薬市場規模:エンドユーザー別
- 病院における市場規模
- 歯科医院における市場規模
- その他エンドユーザーにおける市場規模
・世界の歯科用麻酔薬市場規模:地域別
- 北米の歯科用麻酔薬市場規模
- ヨーロッパの歯科用麻酔薬市場規模
- アジア太平洋の歯科用麻酔薬市場規模
- 中南米の歯科用麻酔薬市場規模
- 中東・アフリカの歯科用麻酔薬市場規模
・競合状況

Dental Anesthetics Market – Scope of Report
TMR’s report on the global dental anesthetics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global dental anesthetics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dental anesthetics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dental anesthetics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dental anesthetics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dental anesthetics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dental anesthetics market.

The report delves into the competitive landscape of the global dental anesthetics market. Key players operating in the global dental anesthetics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global dental anesthetics market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market dental anesthetics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Anesthetics Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Dental Anesthetics Market Analysis and Forecast, 2017–2031
    4.5. Porter’s Five Forces Analysis
5. Key Insights
    5.1. Insights on number of dental surgical procedures
    5.2. Regulatory Scenario by Region/Globally
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Dental Anesthetics Market Analysis and Forecast, by Type of Anesthesia
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Type of Anesthesia, 2017–2031
        6.3.1. Local Anesthesia
            6.3.1.1. Articaine
            6.3.1.2. Bupivacaine
            6.3.1.3. Lidocaine
            6.3.1.4. Others
        6.3.2. General Anesthesia
        6.3.3. Sedation
    6.4. Market Attractiveness Analysis, by Type of Anesthesia
7. Global Dental Anesthetics Market Analysis and Forecast, by Route of Administration
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Route of Administration, 2017–2031
        7.3.1. Oral
        7.3.2. Intravenous
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Dental Anesthetics Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Dental Clinics
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Dental Anesthetics Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America (LATAM)
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Dental Anesthetics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
        10.2.1. Local Anesthesia
            10.2.1.1. Articaine
            10.2.1.2. Bupivacaine
            10.2.1.3. Lidocaine
            10.2.1.4. Others
        10.2.2. General Anesthesia
        10.2.3. Sedation
    10.3. Market Value Forecast, by Route of Administration, 2017–2031
        10.3.1. Oral
        10.3.2. Intravenous
        10.3.3. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Dental Clinics
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Type of Anesthesia
        10.6.2. By Route of Administration
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Dental Anesthetics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
        11.2.1. Local Anesthesia
            11.2.1.1. Articaine
            11.2.1.2. Bupivacaine
            11.2.1.3. Lidocaine
            11.2.1.4. Others
        11.2.2. General Anesthesia
        11.2.3. Sedation
    11.3. Market Value Forecast, by Route of Administration, 2017–2031
        11.3.1. Oral
        11.3.2. Intravenous
        11.3.3. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Dental Clinics
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Type of Anesthesia
        11.6.2. By Route of Administration
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Dental Anesthetics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
        12.2.1. Local Anesthesia
            12.2.1.1. Articaine
            12.2.1.2. Bupivacaine
            12.2.1.3. Lidocaine
            12.2.1.4. Others
        12.2.2. General Anesthesia
        12.2.3. Sedation
    12.3. Market Value Forecast, by Route of Administration, 2017–2031
        12.3.1. Oral
        12.3.2. Intravenous
        12.3.3. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Dental Clinics
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Type of Anesthesia
        12.6.2. By Route of Administration
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Dental Anesthetics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
        13.2.1. Local Anesthesia
            13.2.1.1. Articaine
            13.2.1.2. Bupivacaine
            13.2.1.3. Lidocaine
            13.2.1.4. Others
        13.2.2. General Anesthesia
        13.2.3. Sedation
    13.3. Market Value Forecast, by Route of Administration, 2017–2031
        13.3.1. Oral
        13.3.2. Intravenous
        13.3.3. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Dental Clinics
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Type of Anesthesia
        13.6.2. By Route of Administration
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Anesthetics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
        14.2.1. Local Anesthesia
            14.2.1.1. Articaine
            14.2.1.2. Bupivacaine
            14.2.1.3. Lidocaine
            14.2.1.4. Others
        14.2.2. General Anesthesia
        14.2.3. Sedation
    14.3. Market Value Forecast, by Route of Administration, 2017–2031
        14.3.1. Oral
        14.3.2. Intravenous
        14.3.3. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Dental Clinics
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of MEA
    14.6. Market Attractiveness Analysis
        14.6.1. By Type of Anesthesia
        14.6.2. By Route of Administration
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2021
    15.3. Company Profiles
        15.3.1. Dentsply Sirona
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Laboratorios Inibsa
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Pierrel SPA
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Septodont
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Laboratorios Normon
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Primex Pharmaceuticals
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Aspen Group
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Dentalhitec
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Zeyco
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
        15.3.10. Crosstex International, Inc.
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Financial Overview
            15.3.10.5. Strategic Overview
        15.3.11. Centrix, Inc.
            15.3.11.1. Company Overview
            15.3.11.2. Product Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Financial Overview
            15.3.11.5. Strategic Overview
        15.3.12. 3M
            15.3.12.1. Company Overview
            15.3.12.2. Product Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Financial Overview
            15.3.12.5. Strategic Overview
        15.3.13. Southern Anesthesia & Surgical, Inc.
            15.3.13.1. Company Overview
            15.3.13.2. Product Portfolio
            15.3.13.3. SWOT Analysis
            15.3.13.4. Financial Overview
            15.3.13.5. Strategic Overview
        15.3.14. Milestone Scientific
            15.3.14.1. Company Overview
            15.3.14.2. Product Portfolio
            15.3.14.3. SWOT Analysis
            15.3.14.4. Financial Overview
            15.3.14.5. Strategic Overview

List of Tables

Table 01: Global Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 02: Global Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 03: Global Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Dental Anesthetics Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Dental Anesthetics Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 07: North America Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 08: North America Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Dental Anesthetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 11: Europe Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 12: Europe Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Dental Anesthetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 15: Asia Pacific Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 16: Asia Pacific Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Dental Anesthetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 19: Latin America Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 20: Latin America Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Dental Anesthetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Dental Anesthetics Market Size (US$ Mn) Forecast, by Type of Anesthesia, 2017–2031

Table 23: Middle East & Africa Dental Anesthetics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 24: Middle East & Africa Dental Anesthetics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 歯科用麻酔薬の世界市場2022~2031:麻酔種類別(Dental Anesthetics Market (Type of Anesthesia: Local Anesthesia, General Anesthesia, and Sedation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆